HOME
Introduction
Legal Notices and Disclaimers
Privacy Policy
Search
Sitemap
ABOUT US
Board of Directors
Management
Business Development
PRODUCTS
RESEARCH & DEVELOPMENT
XenoPort Pipeline
Arbaclofen Placarbil
XP21279
XP23829
Our Technology
     Exploiting Transporters
     Enhancing Oral Bioavailability
INVESTORS
Calendar of Events
Press Releases
SEC Filings
Stock Information
Corporate Governance
Management
Analysts
Investor FAQ
Online Investor Kit
Ownership Summary
Annual Reports
CAREERS
 CONTACT US
Directions to Xenoport